Colitis-Associated Variant of TLR2 Causes Impaired Mucosal Repair Because of TFF3 Deficiency

Gastroenterology

Volumn 137, Issue 1, 2009, Pages 209-220

  Podolsky, Daniel K ^a,b   Gerken, Guido ^c   Eyking, Annette ^c   Cario, Elke ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; MUTANT PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 2 AGONIST; TOLL LIKE RECEPTOR AGONIST; TREFOIL FACTOR 3; TREFOIL PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIUM; CELL ASSAY; CELL PROTECTION; COLON INJURY; COMMENSAL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EX VIVO STUDY; GENE; GENE FUNCTION; GENETIC POLYMORPHISM; GOBLET CELL; HOST; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; INTESTINE; INTESTINE MUCOSA; MORBIDITY; MORTALITY; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TISSUE REPAIR; TOLL LIKE RECEPTOR 2 GENE; ULCERATIVE COLITIS; WESTERN BLOTTING; WILD TYPE; WOUND HEALING IMPAIRMENT;

EID: 67649231565     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.03.007     Document Type: Article

References (37)

1. Taupin D., and Podolsky D.K. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 4 (2003) 721-732
2. Mashimo H., Wu D.C., Podolsky D.K., et al. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274 (1996) 262-265
3. Furuta G.T., Turner J.R., Taylor C.T., et al. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med 193 (2001) 1027-1034
4. Beck P.L., Wong J.F., Li Y., et al. Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor. Gastroenterology 126 (2004) 796-808
5. Dignass A., Lynch-Devaney K., Kindon H., et al. Trefoil peptides promote epithelial migration through a transforming growth factor β-independent pathway. J Clin Invest 94 (1994) 376-383
6. Hooper L.V., Wong M.H., Thelin A., et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291 (2001) 881-884
7. Xavier R.J., and Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448 (2007) 427-434
8. Cario E. Innate immune signalling at intestinal mucosal surfaces: a fine line between host protection and destruction. Curr Opin Gastroenterol 24 (2008) 725-732
9. Jin M.S., Kim S.E., Heo J.Y., et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130 (2007) 1071-1082
10. Cario E., Rosenberg I.M., Brandwein S.L., et al. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 164 (2000) 966-972
11. Palazzo M., Balsari A., Rossini A., et al. Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion. J Immunol 178 (2007) 4296-4303
12. Cario E., Gerken G., and Podolsky D.K. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127 (2004) 224-238
13. Cario E., Gerken G., and Podolsky D.K. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132 (2007) 1359-1374
14. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118 (2004) 229-241
15. Pierik M., Joossens S., Van Steen K., et al. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 12 (2006) 1-8
16. Itoh H., Beck P.L., Inoue N., et al. A paradoxical reduction in susceptibility to colonic injury upon targeted transgenic ablation of goblet cells. J Clin Invest 104 (1999) 1539-1547
17. Wooten R.M., Ma Y., Yoder R.A., et al. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J Immunol 168 (2002) 348-355
18. Buwitt-Beckmann U., Heine H., Wiesmuller K.H., et al. TLR1- and TLR6-independent recognition of bacterial lipopeptides. J Biol Chem 281 (2006) 9049-9057
19. Taupin D., Wu D.C., Jeon W.K., et al. The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor- and MAP kinase-dependent interregulation. J Clin Invest 103 (1999) R31-R38
20. Paulsen F.P., Woon C.W., Varoga D., et al. Intestinal trefoil factor/TFF3 promotes re-epithelialization of corneal wounds. J Biol Chem 283 (2008) 13418-13427
21. Taupin D.R., Kinoshita K., and Podolsky D.K. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc Natl Acad Sci U S A 97 (2000) 799-804
22. Kinoshita K., Taupin D.R., Itoh H., et al. Distinct pathways of cell migration and antiapoptotic response to epithelial injury: structure-function analysis of human intestinal trefoil factor. Mol Cell Biol 20 (2000) 4680-4690
23. Gustafsson A.C., Kupershmidt I., Edlundh-Rose E., et al. Global gene expression analysis in time series following N-acetyl L-cysteine induced epithelial differentiation of human normal and cancer cells in vitro. BMC Cancer 5 (2005) 75
24. Chang Y.J., Wu M.S., Lin J.T., et al. Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-κB activation. Mol Pharmacol 66 (2004) 1465-1477
25. Durual S., Blanchard C., Estienne M., et al. Expression of human TFF3 in relation to growth of HT-29 cell subpopulations: involvement of PI3-K but not STAT6. Differentiation 73 (2005) 36-44
26. Iwakiri D., and Podolsky D.K. A silencer inhibitor confers specific expression of intestinal trefoil factor in gobletlike cell lines. Am J Physiol Gastrointest Liver Physiol 280 (2001) G1114-G1123
27. Cario E. Barrier-protective function of intestinal epithelial Toll-like receptor 2. Mucosal Immunol Suppl 1 (2008) S62-S66
28. Iwakiri D., and Podolsky D.K. Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor. Gastroenterology 120 (2001) 1372-1380
29. Katz J.P., Perreault N., Goldstein B.G., et al. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 129 (2002) 2619-2628
30. Yang Q., Bermingham N.A., Finegold M.J., et al. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 294 (2001) 2155-2158
31. Shroyer N.F., Wallis D., Venken K.J., et al. Gfi1 functions downstream of Math1 to control intestinal secretory cell subtype allocation and differentiation. Genes Dev 19 (2005) 2412-2417
32. Pull S.L., Doherty J.M., Mills J.C., et al. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci U S A 102 (2005) 99-104
33. Housley R.M., Morris C.F., Boyle W., et al. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest 94 (1994) 1764-1777
34. Tebbutt N.C., Giraud A.S., Inglese M., et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med 8 (2002) 1089-1097
35. Twiddy D., Cohen G.M., Macfarlane M., et al. Caspase-7 is directly activated by the approximately 700-kDa apoptosome complex and is released as a stable XIAP-caspase-7 approximately 200-kDa complex. J Biol Chem 281 (2006) 3876-3888
36. Cario E., and Podolsky D.K. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68 (2000) 7010-7017
37. Kanzler H., Barrat F.J., Hessel E.M., et al. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 13 (2007) 552-559